while I wait for the quarterly with the new chairs vision of anteotech's CET division, been doing some research on the life science division.
posted a couple of papers lately about the new tech of ev testing and how anteobind enables the necessary sensitivity for them to work. these are other areas that anteobind is being used in from Gautum and Tek's webinar.
looking at the revenue estimates of each of the above, anteobind with it's 6 separate products only needs to grab a tiny market share to make significant revenues
GLTAH
ADO Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)